Bicara Therapeutics Inc.
Total Trades
35
Buys
1
Sells
18
Largest Trade
$1M+
Insiders
6
Institutional Funds
98
Inst. Value
$1M+
Activist Filings
18
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Cohlhepp Ryan | President and COO | SELL | $100K–$500K | 17K | $18.16 | Mar 6, 2026 |
| Cohlhepp Ryan | President and COO | EXERCISE | $15K–$50K | 13K | $3.79 | Mar 6, 2026 |
| Hyep Ivan | CFO | SELL | $100K–$500K | 17K | $18.22 | Mar 6, 2026 |
| Hyep Ivan | CFO | EXERCISE | $50K–$100K | 17K | $3.79 | Mar 6, 2026 |
| Raben David | Chief Medical Offi… | EXERCISE | $50K–$100K | 17K | $3.79 | Mar 6, 2026 |
| Raben David | Chief Medical Offi… | SELL | $100K–$500K | 17K | $18.52 | Mar 6, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Director | BUY | $1M+ | 300K | $16.00 | Mar 2, 2026 |
| Cohlhepp Ryan | President and COO | EXERCISE | $1K–$15K | 3K | $3.79 | Feb 27, 2026 |
| Cohlhepp Ryan | President and COO | SELL | $50K–$100K | 4K | $18.04 | Feb 27, 2026 |
| Cohlhepp Ryan | President and COO | SELL | $50K–$100K | 4K | $18.10 | Jan 26, 2026 |
| Hyep Ivan | CFO | EXERCISE | $1K–$15K | 2K | $3.79 | Jan 26, 2026 |
| Hyep Ivan | CFO | SELL | $15K–$50K | 2K | $18.15 | Jan 26, 2026 |
| Cohlhepp Ryan | President and COO | SELL | $1K–$15K | 149 | $18.02 | Jan 20, 2026 |
| Hyep Ivan | CFO | EXERCISE | $15K–$50K | 9K | $3.79 | Dec 23, 2025 |
| Hyep Ivan | CFO | SELL | $100K–$500K | 9K | $18.31 | Dec 23, 2025 |
| Cohlhepp Ryan | President and COO | EXERCISE | $15K–$50K | 8K | $3.79 | Dec 16, 2025 |
| Cohlhepp Ryan | President and COO | SELL | $100K–$500K | 13K | $18.68 | Dec 16, 2025 |
| Hyep Ivan | CFO | EXERCISE | $50K–$100K | 18K | $3.79 | Nov 25, 2025 |
| Hyep Ivan | CFO | SELL | $100K–$500K | 18K | $18.54 | Nov 25, 2025 |
| Cohlhepp Ryan | President and COO | SELL | $100K–$500K | 13K | $18.05 | Nov 25, 2025 |
| Cohlhepp Ryan | President and COO | EXERCISE | $15K–$50K | 8K | $3.79 | Nov 25, 2025 |
| Mazumdar Claire | CEO | SELL | $500K+ | 41K | $18.86 | Nov 25, 2025 |
| Mazumdar Claire | CEO | EXERCISE | $100K–$500K | 41K | $3.79 | Nov 25, 2025 |
| Raben David | Chief Medical Offi… | SELL | $100K–$500K | 11K | $18.65 | Nov 25, 2025 |
| Raben David | Chief Medical Offi… | EXERCISE | $15K–$50K | 11K | $3.79 | Nov 25, 2025 |
| Mazumdar Claire | CEO | SELL | $100K–$500K | 24K | $18.83 | Oct 20, 2025 |
| Mazumdar Claire | CEO | EXERCISE | $50K–$100K | 24K | $3.79 | Oct 20, 2025 |
| Meisner Lara | Chief Legal Officer | EXERCISE | $100K–$500K | 34K | $9.24 | Oct 1, 2025 |
| Meisner Lara | Chief Legal Officer | SELL | $100K–$500K | 34K | $14.75 | Oct 1, 2025 |
| Meisner Lara | Chief Legal Officer | SELL | $100K–$500K | 16K | $11.49 | Sep 17, 2025 |
| Meisner Lara | Chief Legal Officer | EXERCISE | $50K–$100K | 16K | $5.45 | Sep 17, 2025 |
| Meisner Lara | Chief Legal Officer | SELL | $100K–$500K | 16K | $10.43 | Jun 18, 2025 |
| Meisner Lara | Chief Legal Officer | EXERCISE | $50K–$100K | 16K | $5.45 | Jun 18, 2025 |
| Meisner Lara | Chief Legal Officer | SELL | $1M+ | 79K | $12.90 | Mar 18, 2025 |
| Meisner Lara | Chief Legal Officer | EXERCISE | $100K–$500K | 79K | $5.45 | Mar 18, 2025 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 98 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 7.0M | $1M+ | SH |
| Siren, L.L.C. | 5.2M | $1M+ | SH |
| Red Tree Management, LLC | 3.2M | $1M+ | SH |
| TPG GP A, LLC | 3.0M | $1M+ | SH |
| Deep Track Capital, LP | 2.6M | $1M+ | SH |
| STATE STREET CORP | 1.6M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 708K | $1M+ | SH |
| Aisling Capital Management LP | 569K | $1M+ | SH |
| Ensign Peak Advisors, Inc | 401K | $1M+ | SH |
| NAN FUNG TRINITY (HK) Ltd | 372K | $1M+ | SH |
| Clearbridge Investments, LLC | 299K | $1M+ | SH |
| Palo Alto Investors LP | 299K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 272K | $1M+ | SH |
| TD ASSET MANAGEMENT INC | 245K | $1M+ | SH |
| ORBIMED ADVISORS LLC | 209K | $1M+ | SH |
| UBS Group AG | 192K | $1M+ | SH |
| Hudson Bay Capital Management LP | 150K | $1M+ | SH |
| Napean Trading & Investment Co (Singapore) PTE Ltd | 114K | $1M+ | SH |
| Atle Fund Management AB | 111K | $1M+ | SH |
| BARCLAYS PLC | 103K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D/A · Mar 2, 2026
11.5%
7.3M shares
SC 13G · Feb 12, 2026
5.0%
2.8M shares
SC 13G/A · Feb 5, 2026
6.1%
3.3M shares
SC 13G/A · Aug 14, 2025
9.2%
5.0M shares
SC 13G/A · Jul 31, 2025
8.9%
4.9M shares
SC 13G · Jul 17, 2025
5.1%
2.8M shares
SC 13G/A · Jul 17, 2025
4.7%
2.5M shares
SC 13G · May 15, 2025
5.1%
2.8M shares
SC 13G/A · May 12, 2025
6.6%
3.6M shares
SC 13G · Mar 3, 2025
5.2%
2.8M shares
SC 13G/A · Feb 12, 2025
3.9%
2.1M shares
SC 13G · Sep 26, 2024
5.6%
3.0M shares
SC 13G · Sep 26, 2024
5.8%
3.2M shares
Longitude Capital Partners IV, LLC 2
SC 13D · Sep 24, 2024
4.1%
1.7M shares
SC 13D · Sep 23, 2024
12.8%
7.0M shares
SC 13D · Sep 23, 2024
9.0%
3.8M shares
SC 13D · Sep 18, 2024
5.5%
3.0M shares
SC 13G · Sep 18, 2024
5.1%
2.5M shares